European Ban on Positive Coverage of Unapproved Drugs Tramples on Free Speech


The European Court of Justice recently ruled that writing positively about drugs that haven't been approved for sale by government officials constitutes advertising and thus can be prohibited. This ruling has potentially disastrous ramifications on medically oriented free speech in Europe, writes Peter Pitts, of the PR firm Porter Novelli.

No Responses to “European Ban on Positive Coverage of Unapproved Drugs Tramples on Free Speech”

Post a Comment